Production of IL-1β by bone marrow-derived macrophages in response to chemotherapeutic drugs
Open Access
- 9 July 2014
- journal article
- Published by Taylor & Francis in Cancer Biology & Therapy
- Vol. 15 (10) , 1395-1403
Abstract
Cytotoxic chemotherapeutic drugs, especially when used in combination, are widely employed to treat a variety of cancers in patients but often lead to serious symptoms that negatively affect physic...Keywords
This publication has 57 references indexed in Scilit:
- Cytokines as Mediators of Chemotherapy-Associated Cognitive Changes: Current Evidence, Limitations and Directions for Future ResearchPLOS ONE, 2013
- Activation and regulation of the inflammasomesNature Reviews Immunology, 2013
- An Unusual Presentation of Tumor Lysis Syndrome in a Patient with Advanced Gastric Adenocarcinoma: Case Report and Literature ReviewCase Reports in Medicine, 2012
- Nilotinib Counteracts P-Glycoprotein-Mediated Multidrug Resistance and Synergizes the Antitumoral Effect of Doxorubicin in Soft Tissue SarcomasPLOS ONE, 2012
- Suppression of Ribosomal Function Triggers Innate Immune Signaling through Activation of the NLRP3 InflammasomePLOS ONE, 2012
- AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based ResistanceCancer Cell, 2009
- Imatinib and Nilotinib Reverse Multidrug Resistance in Cancer Cells by Inhibiting the Efflux Activity of the MRP7 (ABCC10)PLOS ONE, 2009
- Inhibition of p38 MAPK Suppresses Inflammatory Cytokine Induction by Etoposide, 5-Fluorouracil, and Doxorubicin without Affecting Tumoricidal ActivityPLOS ONE, 2008
- AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABLBritish Journal of Cancer, 2006
- Fatigue in Women Receiving Adjuvant Chemotherapy for Breast CancerJournal of Pain and Symptom Management, 1999